logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

ELIFE HLDGS (00223) issued 85.5 million share options and 9.3 million bonus shares.

date
19:02 06/05/2026
avatar
GMT Eight
Easy Life Holdings (00223) announced that on May 6, 2026, the company granted a total of 85.5 million share options and 9.3 million new shares as rewards, with an exercise price of HK$0.131 per share.
ELIFE HLDGS(00223) announced that on May 6, 2026, the company granted a total of 85.5 million share options and 9.3 million new shares as incentives, with an exercise price of HK$0.131 per share.
Related Articles
HK Stock
Ningbo Joyson Electronic Corp. (00699) spent 4.1666 million Hong Kong dollars on May 6 to repurchase 240,000 shares.
China Stock
Changchun High-Tech Industry(000661.SZ) subsidiary Fuxinqibaixi monoclonal antibody injection has been approved for listing in the domestic market.
HK Stock
AK MEDICAL (01789) spent 6.257 million Hong Kong dollars on May 6 to repurchase 100.6 million shares.
Ningbo Joyson Electronic Corp. (00699) spent 4.1666 million Hong Kong dollars on May 6 to repurchase 240,000 shares.
HK Stock
Changchun High-Tech Industry(000661.SZ) subsidiary Fuxinqibaixi monoclonal antibody injection has been approved for listing in the domestic market.
China Stock
AK MEDICAL (01789) spent 6.257 million Hong Kong dollars on May 6 to repurchase 100.6 million shares.
HK Stock
RECOMMEND
HKEX Signals Stronger Reforms While Upholding Listing Quality
HKEX Signals Stronger Reforms While Upholding Listing Quality
icon
02/05/2026
Retreat of Short Sellers Opens Valuation Window for Hong Kong’s AI Leaders
Retreat of Short Sellers Opens Valuation Window for Hong Kong’s AI Leaders
icon
02/05/2026
Explosive Token Growth Signals New Stage for China’s AI
Explosive Token Growth Signals New Stage for China’s AI
icon
02/05/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.